IRMD earnings date and last-quarter result: next report 2026-07-30, last quarter beat, P/E 50.58. Updated 2026-07-23.
IRadimed (IRMD) Research Hub
IRadimed (IRMD) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 84.63 USD (-1.39%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 50.58, market cap 1.21B. This hub links to the full technical, earnings and options research available for IRMD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 84.63 USD (-1.39%) |
| 52-week range | 81.41 USD – 102.99 USD |
| Trend regime | Range |
| 14-day RSI | 49.2 (Neutral) |
| Trailing P/E | 50.58 |
| Market cap | 1.21B |
| Dividend yield | 1.32% |
| Next earnings | 2026-07-30 |
Available research for IRMD
Covered Call on IRMD: how it works, illustrative setup around the real 84.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IRMD: how it works, illustrative setup around the real 84.63 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IRMD: how it works, illustrative setup around the real 84.63 USD price, max profit/loss, breakeven and when to use it. Educational.
IRMD technical analysis: range, last 84.63 USD, RSI 49.2, 52w range 81.41 USD–102.99 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IRMD in?
IRadimed (IRMD) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is IRMD in an uptrend or downtrend?
As of 2026-10-26, IRMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IRMD's trailing P/E ratio?
IRMD's trailing P/E is 50.58, with a market cap of 1.21B. See the earnings research page for full valuation detail.
When does IRMD next report earnings?
IRMD is next scheduled to report earnings on 2026-07-30.